Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (DE:818)
FRANKFURT:818
Holding DE:818?
Track your performance easily
818 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€1.05 - €1.54
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€459.40M
Enterprise Value€2.07B
Total Cash (Recent Filing)$98.13M
Total Debt (Recent Filing)$8.00M
Price to Earnings (P/E)126.9
Beta0.72
Next Earnings
Mar 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding322,400,760
10 Day Avg. Volume0
30 Day Avg. Volume0
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap4.51
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit15.70
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Zylox-Tonbridge Medical Technology Co., Ltd. Class H News
PremiumCompany Announcements
Zylox-Tonbridge Announces Change of Business Address in Hong Kong
PremiumCompany Announcements
Zylox-Tonbridge Grants Share Awards to Boost Performance
PremiumCompany Announcements
Zylox-Tonbridge Approves Key Resolutions in EGM
PremiumCompany Announcements
Zylox-Tonbridge’s Strategic Moves with Share Award SchemePremiumCompany Announcements
Zylox-Tonbridge’s Secretary Gains Independent Qualification
PremiumCompany Announcements
Zylox-Tonbridge Announces 2024 Shareholder Meeting PlansPremiumCompany Announcements
Zylox-Tonbridge Proposes New Share Award Scheme
PremiumCompany Announcements
Zylox-Tonbridge Reports Soaring H1 2024 ProfitsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.19% Mutual Funds
― Other Institutional Investors
97.67% Public Companies and
Individual Investors
818 FAQ
What was Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s price range in the past 12 months?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H lowest stock price was €1.05 and its highest was €1.54 in the past 12 months.
What is Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s market cap?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s market cap is €459.40M.
When is Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s upcoming earnings report date?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s upcoming earnings report date is Mar 18, 2025 which is in 45 days.
How were Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s earnings last quarter?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H released its earnings results on Aug 26, 2024. The company reported €0.028 earnings per share for the quarter, beating the consensus estimate of N/A by €0.028.
Is Zylox-Tonbridge Medical Technology Co., Ltd. Class H overvalued?
According to Wall Street analysts Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s price is currently Overvalued.
Does Zylox-Tonbridge Medical Technology Co., Ltd. Class H pay dividends?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H does not currently pay dividends.
What is Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s EPS estimate?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zylox-Tonbridge Medical Technology Co., Ltd. Class H have?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H has 322,400,760 shares outstanding.
What happened to Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s price movement after its last earnings report?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H reported an EPS of €0.028 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.39%.
Which hedge fund is a major shareholder of Zylox-Tonbridge Medical Technology Co., Ltd. Class H?
Currently, no hedge funds are holding shares in DE:818
---
Company Description
Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co Ltd is committed towards the development and production of medical devices in the peripheral and neurointervention fields. It provides humanized medical services and advanced overall solutions for doctors and patients in China and overseas.
---
Technical Analysis
CSPC Pharmaceutical Group
―
Tong Ren Tang Technologies Co
―
Wuxi Biologics (Cayman)
―
Top Education Group Ltd.
―
Shanghai Haohai Biological Technology Co., Ltd. Class H
―
---